Skip to main content
. 2021 Dec 16;11(12):2375. doi: 10.3390/diagnostics11122375

Table 4.

Concordance of plasma ctDNA by NGS and standard tissue RAS testing (n = 30).

Tissue RAS Status
RAS Mutant WT Total PPA NPA OPA
Plasma ctDNA RAS status by NGS Mutant 13 1 14 100 × 13/16 = 81.2% 100 × 13/14 = 92.8% 100 × 26/30 = 86.7%
WT 3 13 16
Total 16 14 30

ctDNA: circulating tumor DNA; dPCR: digital PCR; NGS: Next-generation sequencing; WT: Wild type; PPA: Positive percent agreement; NPA: Negative percent agreement; OPA: Overall percent agreement.